Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Avatrombopag

Headache and liver toxicity

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mingot Castellano ME, et al. Avatrombopag Plus Fostamatinib Combination Efficacy and Safety in Patients with Immune Thrombocytopenia. Blood 142 (Suppl.): 2596, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-187518 [abstract] Mingot Castellano ME, et al. Avatrombopag Plus Fostamatinib Combination Efficacy and Safety in Patients with Immune Thrombocytopenia. Blood 142 (Suppl.): 2596, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-187518 [abstract]
Metadaten
Titel
Avatrombopag
Headache and liver toxicity
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55976-z

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Disulfiram

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs